These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 6723760)

  • 21. The influence of enteral feedings on sustained-release theophylline absorption.
    Plezia PM; Thornley SM; Kramer TH; Armstrong EP
    Pharmacotherapy; 1990; 10(5):356-61. PubMed ID: 2122422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inconsistent absorption from a sustained-release theophylline preparation during continuous therapy in asthmatic children.
    Rogers RJ; Kalisker A; Wiener MB; Szefler SJ
    J Pediatr; 1985 Mar; 106(3):496-501. PubMed ID: 3973788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Study of bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms as assessed by salivary data: Part II.
    Ohmori N; Inotsume N; Matsukura M; Higashi A; Iwaoku R; Tobino Y; Nakano M; Matsuda I
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):196-201. PubMed ID: 3710632
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic disposition of an immediate-release aminophylline and a sustained-release theophylline formulation in the horse.
    Goetz TE; Munsiff IJ; McKiernan BC
    J Vet Pharmacol Ther; 1989 Dec; 12(4):369-77. PubMed ID: 2614856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioavailability of Theodel, a new theophylline tablet, in humans.
    Rovei V; Strolin Benedetti M; Donath A; Grenot C; Chanoine F
    Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):425-30. PubMed ID: 6629546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of food on the rate and extent of absorption of theophylline after single dose oral administration of a controlled release tablet.
    Lagas M; Jonkman JH
    Int J Clin Pharmacol Ther Toxicol; 1985 Aug; 23(8):424-6. PubMed ID: 4044074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of a sustained-release theophylline formulation.
    Trembath PW; Boobois SW
    Br J Clin Pharmacol; 1980 Apr; 9(4):365-9. PubMed ID: 7378252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Contin delivery system: dosing considerations.
    Leslie S
    J Allergy Clin Immunol; 1986 Oct; 78(4 Pt 2):768-73. PubMed ID: 3771963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinetics of intravenous theophylline.
    Chrzanowski FA; Niebergall PJ; Mayock RL; Taubin JM; Sugita ET
    Clin Pharmacol Ther; 1977 Aug; 22(2):188-95. PubMed ID: 884920
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic properties of a new sustained-release theophylline preparation.
    Dahlqvist R; Billing B
    Int J Clin Pharmacol Ther Toxicol; 1983 Feb; 21(2):69-72. PubMed ID: 6840927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of diurnal changes in the disposition of theophylline.
    Taylor DR; Duffin D; Kinney CD; McDevitt DG
    Br J Clin Pharmacol; 1983 Oct; 16(4):413-6. PubMed ID: 6684947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the bioavailability and pharmacokinetics of two extended-release theophylline formulations in dogs.
    Bach JE; Kukanich B; Papich MG; McKiernan BC
    J Am Vet Med Assoc; 2004 Apr; 224(7):1113-9. PubMed ID: 15074856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of food on the bioavailability and pattern of release of a sustained-release theophylline tablet.
    Leeds NH; Gal P; Purohit AA; Walter JB
    J Clin Pharmacol; 1982 Apr; 22(4):196-200. PubMed ID: 7096605
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of a sustained-release theophylline preparation in healthy subjects.
    Goto M; Nakamoto Y; Sugiyama M; Yamashina H
    J Pharmacobiodyn; 1983 Apr; 6(4):225-31. PubMed ID: 6620110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Food does not effect in bioavailability of theophylline from Theolin Retard.
    Sips AP; Edelbroek PM; Kulstad S; de Wolff FA; Dijkman JH
    Eur J Clin Pharmacol; 1984; 26(3):405-7. PubMed ID: 6734703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absorption of theophylline from conventional and sustained-release tablets.
    Mellstrand T; Svedmyr N; Fagerström PO
    Eur J Respir Dis Suppl; 1980; 109():54-60. PubMed ID: 6934088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Food induced changes in theophylline absorption from a once-a-day theophylline product.
    Steffensen G; Pedersen S
    Br J Clin Pharmacol; 1986 Nov; 22(5):571-7. PubMed ID: 3790404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The relation of product formulation to absorption of oral theophylline.
    Weinberger M; Hendeles L; Bighley L
    N Engl J Med; 1978 Oct; 299(16):852-7. PubMed ID: 692577
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative bioavailability of a microcrystalline theophylline tablet and uncoated aminophylline tablets.
    Sansom LN; Milne RW; Cooper D
    Eur J Clin Pharmacol; 1979; 16(6):417-21. PubMed ID: 583332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Conversion from intravenous aminophylline to sustained-release theophylline: computer simulation versus in vivo results.
    Hatton RC; Gotz VP; Robinson JD; Russell WL; Ryerson GG
    Clin Pharm; 1983; 2(4):347-52. PubMed ID: 6883961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.